RaQualia Pharma Inc. - ROE
4579.T
Price:
$542
Market Cap:
$13.26B
RaQualia Pharma Inc., established in 2008 and based in Nagoya, Japan, is a pharmaceutical company dedicated to the global research and development of innovative drug compounds. Its human therapeutic pipeline features several key candidates. Tegoprazan, designed to treat gastroesophageal reflux disease (GERD), is currently undergoing Phase 1 clinical trials in the United States. Grapiprant is in Phase II development in the U.S. and Phase I in China for pain management; it is also being investigated in Phase I studies in both the U.S. and China for its potential in cancer therapy. Beyond human medicines, RaQualia Pharma develops a range of veterinary products. These include grapiprant for mana...[Read more]
Industry
Biotechnology
IPO Date
2011-07-20
Stock Exchange
JPX
Ticker
4579.T
PE Ratio
[182.34]
ROE
[2.23%]
Current Ratio
[5.78]
Dividend Yield
[0%]
Enterprise Value
[11.37B]
Dividend History
The ROE as of September 2026 (TTM) for RaQualia Pharma Inc. (4579.T) is 2.23%
According to RaQualia Pharma Inc.’s latest financial reports and current stock price. The company's current ROE is 2.23%. This represents a change of 219.54% compared to the average of 0.70% of the last 4 quarters.
RaQualia Pharma Inc. (4579.T) Historical ROE (quarterly & annually)
How has 4579.T ROE performed in the past?
The mean historical ROE of RaQualia Pharma Inc. over the last ten years is -4.53%. The current 2.23% ROE has changed -149.30% with respect to the historical average. Over the past ten years (40 quarters), 4579.T's ROE was at its highest in in the December 2021 quarter at 12.25%. The ROE was at its lowest in in the September 2016 quarter at -7.94%.
Average
-4.53%
Median
-3.24%
Minimum
-28.64%
Maximum
15.79%
RaQualia Pharma Inc. (4579.T) ROE by Quarter and Year
Discovering the peaks and valleys of RaQualia Pharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.31%
Maximum Annual ROE = 15.79%
Minimum Annual Increase = -13186.66%
Minimum Annual ROE = -28.64%
| Year | ROE | Change |
|---|---|---|
| 2025 | 3.96% | -144.57% |
| 2024 | -8.89% | 68.05% |
| 2023 | -5.29% | -140.18% |
| 2022 | 13.16% | -16.63% |
| 2021 | 15.79% | -204.31% |
| 2020 | -15.13% | -13186.66% |
| 2019 | 0.12% | -100.40% |
| 2018 | -28.64% | 2.31% |
| 2017 | -1.19% | -93.81% |
| 2016 | -19.22% | -53.21% |
RaQualia Pharma Inc. (4579.T) Average ROE
How has 4579.T ROE performed in the past?
The current ROE of RaQualia Pharma Inc. (4579.T) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.40%
5-year avg
3.75%
10-year avg
-4.53%
RaQualia Pharma Inc. (4579.T) ROE vs. Peers
How is 4579.T’s ROE compared to its peers?
RaQualia Pharma Inc.’s ROE is greater than NANO MRNA Co.,Ltd. (-33.61%), greater than MediciNova, Inc. (-26.51%), greater than CellSeed Inc. (-66.94%), greater than Japan Medical Dynamic Marketing, Inc. (-0.89%), greater than Kidswell Bio Corporation (-19.63%), greater than CanBas Co., Ltd. (-60.26%), greater than Stella Pharma Corporation (-30.36%), less than Techno Medica Co., Ltd. (8.55%), less than Daiken Medical Co., Ltd. (11.38%), greater than Chiome Bioscience Inc. (-70.53%),
| Company | ROE | Market cap |
|---|---|---|
| -33.61% | $8.32B | |
| -26.51% | $13.29B | |
| -66.94% | $8.63B | |
| -0.89% | $16.79B | |
| -19.63% | $8.09B | |
| -60.26% | $14.46B | |
| -30.36% | $14.80B | |
| 8.55% | $13.53B | |
| 11.38% | $12.18B | |
| -70.53% | $6.25B |
Build a custom stock screener for RaQualia Pharma Inc. (4579.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RaQualia Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
RaQualia Pharma Inc. (4579.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like RaQualia Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is RaQualia Pharma Inc.'s ROE?
How is the ROE calculated for RaQualia Pharma Inc. (4579.T)?
What is the highest ROE for RaQualia Pharma Inc. (4579.T)?
What is the 3-year average ROE for RaQualia Pharma Inc. (4579.T)?
What is the 5-year average ROE for RaQualia Pharma Inc. (4579.T)?
How does the current ROE for RaQualia Pharma Inc. (4579.T) compare to its historical average?